Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Layer 2: The Secondary Patent Estate and the Thicket Once a CoM patent is filed, the IP teams work shifts to building a secondary patent estate designed to cover every commercially valuable attribute of the drug beyond the molecule itself
These oral drugs also present new PA considerations: payers may need to decide whether patients can switch between oral and injectable formulations without restarting the PA process
Potential Benefits of the Combination Why would a healthcare provider consider using both medications
119(3097): p
US$ 26.15
US$ 25.23
US$ 29.48
US$ 26.95
US$ 25.01
